| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7505484 | Drug and Alcohol Dependence | 2014 | 5 Pages |
Abstract
Individuals treated with VEN-XR had more severe withdrawal-like symptoms, which mediated their continued marijuana smoking. Noradrenergic agents, such as VEN-XR, may negatively impact treatment outcomes in cannabis-dependent patients attempting to reduce or stop their use.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Meredith A. Kelly, Martina Pavlicova, Andrew Glass, John J. Mariani, Adam Bisaga, Maria A. Sullivan, Edward V. Nunes, Frances R. Levin,